John H Lee

Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial

Jeffrey S. Miller, Zachary Davis, Erika S. Helgeson et al. · Nature Medicine · 2022 · 107 citations

Life Sciences, Immunology, Infectious Diseases +12

Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells

Yvette Robbins, Sarah Greene, Jay Friedman et al. · eLife · 2020 · 58 citations · Full text

Medicine, Immunology, Oncology +17

Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy

Karin L. Lee, Stephen C. Benz, Kristin C. Hicks et al. · Cancer Immunology Research · 2019 · 27 citations · Full text

Medicine, Immunology, Oncology +17

Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers

Mark P. Rubinstein, Cameron E. Williams, Caroline Mart et al. · The Journal of Immunology · 2022 · 22 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

CD200 Induces Epithelial-to-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma via β-Catenin-Mediated Nuclear Translocation

Seung-Pil Shin, Ah Ra Goh, Hyeon‐Gu Kang et al. · Cancers · 2019 · 18 citations · Full text

Medicine, Cell Biology, Oncology +11